Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Brief ReportBrief Report

High-Dose Fentanyl Patch for Cancer Pain

Sasson Menahem and Pesach Shvartzman
The Journal of the American Board of Family Practice September 2004, 17 (5) 388-390; DOI: https://doi.org/10.3122/jabfm.17.5.388
Sasson Menahem
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pesach Shvartzman
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. ↵
    Muijsers BR, Wagstaff AJ. Transdermal fentanyl—an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs 2001; 61: 2289–307.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    Cherny N. New strategies in opioid therapy for cancer pain. J Oncol Manag 2000; 9: 8–15.
    OpenUrl
  3. ↵
    Skaer TL. Management of pain in the cancer patient. Clin Ther 1993; 15: 638–49.
    OpenUrlPubMedWeb of Science
  4. ↵
    Allan L, Hays H, Jensen NH, et al. Randomized crossover trail of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001; 322: 1154–8.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Sloan PA, Moulin DE, Hays H. A clinical evaluation of the transdermal therapeutic system fentanyl for the treatment of cancer pain. J Pain Symptom Manage 1998; 16: 102–11.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Calis KA, Kohler DR, Corso DM. Transdermally administrated fentanyl for pain management. Clin Pharm 1992; 11: 22–36.
    OpenUrlPubMedWeb of Science
  7. ↵
    Ahmedzai S. New approaches to pain control in patients with cancer. Eur J Cancer 1997; 33 Suppl 6: S8–14.
  8. ↵
    Duragesic (Fentanyl transdermal system) full prescribing information. New Brunswick (NJ): Janssen Pharmaceutica; 2001.
  9. ↵
    Bonica JJ. Treatment of cancer pain: current status and future needs. In: Fields HL, Dubner R, Cervero F, editors. Advances in pain research and therapy. Vol 9. New York (NY): Raven Press; 1985. p. 589–616.
  10. ↵
    Moynihan TJ. Use of opioids in the treatment of severe pain in terminally ill patients; dying should not be painful. Mayo Clin Proc 2003; 78: 1397–579.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    Vielhaber A, Portenoy RK. Advances in cancer pain management. Hematol Oncol Clin North Am 2002; 16: 527–41.
    OpenUrlCrossRefPubMed
  12. ↵
    Billings JA. Palliative care. BMJ 2000; 321: 555–8.
    OpenUrlFREE Full Text
  13. ↵
    Cleary JF. Cancer pain management. Cancer Control 2000; 7: 120–31.
    OpenUrlPubMed
  14. ↵
    Radbruch L, Sabatowski R, Petzke F, Brunsch-Radbruch A, Grond S, Lehmann KA. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients. Palliat Med 2001; 15: 309–21.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Lehr VT, Renaud EA. High transdermal fentanyl requirements in a patient with chronic cancer pain. Ann Pharmacother 1993; 27: 575–8.
    OpenUrlPubMed
  16. ↵
    Simmonds MA, Richenbacher J. Transdermal fentanyl: long-term analgesic studies. J Pain Symptom Manage 1992; 3 Suppl: S36–9.
  17. ↵
    Bleeker CP, Bremer RC, Dongelmans DA, van Dongen RTM, Crul BJ. Inefficacy of high-dose transdermal fentanyl in a patient with neuropathic pain: a case report. Eur J Pain 2001; 5: 325–9.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family Practice: 17 (5)
The Journal of the American Board of Family Practice
Vol. 17, Issue 5
1 Sep 2004
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
High-Dose Fentanyl Patch for Cancer Pain
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
High-Dose Fentanyl Patch for Cancer Pain
Sasson Menahem, Pesach Shvartzman
The Journal of the American Board of Family Practice Sep 2004, 17 (5) 388-390; DOI: 10.3122/jabfm.17.5.388

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
High-Dose Fentanyl Patch for Cancer Pain
Sasson Menahem, Pesach Shvartzman
The Journal of the American Board of Family Practice Sep 2004, 17 (5) 388-390; DOI: 10.3122/jabfm.17.5.388
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Case Report
    • Discussion
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Most Frequently Read Articles of 2019
  • Google Scholar

More in this TOC Section

  • Association of Social Needs with Diabetes Outcomes in an Older Population
  • Insurance Instability Among Community-Based Health Center Patients with Diabetes Post-Affordable Care Act Medicaid Expansion
  • Factors Influencing Changing Scopes of Practice Among Contemporary Graduates of the Nation’s Largest Family Medicine Residency
Show more Brief Report

Similar Articles

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire